Online Program Home
  My Program

All Times EDT

* = applied session       ! = JSM meeting theme

Activity Details

31 * ! Mon, 8/3/2020, 10:00 AM - 11:50 AM Virtual
Combination Therapy Dose-Finding in Oncology Drug Development — Topic Contributed Papers
Biopharmaceutical Section, Section on Bayesian Statistical Science, International Chinese Statistical Association
Organizer(s): Rong Liu, BMS
Chair(s): Olga Marchenko, Bayer
10:05 AM Comparative Review of Phase I Dose-Finding Designs for Drug Combination Trials
Heng Zhou, Merck; Ruitao LIN, The University of Texas MD Anderson Cancer Center
10:25 AM Dual-Agent Drug-Combination Designs for Finding Multiple Maximum Tolerated Dose Combinations in Oncology Phase I Trials
Xin Yang, Novartis
10:45 AM Industry Experience on Combination Therapy Dose-Finding in Oncology Drug Development
Rong Liu, BMS
11:05 AM Emerging Approaches in Combination Phase I Trials: Utilization of Historical Data and the Need to Consider Model Guided Designs and Endpoints Other Than DLTs
Suman Sen, Novartis Pharmaceuticals Corp
11:25 AM Discussant: Cindy Gao, FDA
11:45 AM Floor Discussion